Allergy Community & Information
Friday March 24th 2017

‘Allergy Medication News’ Archives

Qualitest Pharmaceuticals Issues Voluntary, Nationwide Retail Level Recall of Four Lots of Butalbital, Acetaminophen, and Caffeine Tablets

Qualitest Pharmaceuticals today issued a voluntary nationwide  retail level recall of Butalbital, Acetaminophen, and Caffeine Tablets USP, 50mg/325mg/40mg, and Hydrocodone Bitartrate and Acetaminophen  Tablets, USP 7.5mg/500mg. This recall was initiated because an [Read More]

ImmunoCAP(R) Used in Largest Cross-sectional Allergy Study Ever

Phadia, the worldwide leader of in vitro allergy diagnostics, is pleased to contribute to the largest cross-sectional allergy study ever conducted through the use of its ImmunoCAP(R) Specific IgE blood test, the market leading in vitro allergy diagnostic test. The landmark [Read More]

Perrigo’s Partner Synthon Receives FDA Tentative Approval for Levocetirizine Solution – Generic Equivalent to Xyzal® Oral Solution

Perrigo Company (Nasdaq: PRGO; TASE) and its partner Synthon Pharmaceuticals, Inc. today announced that it has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Levocetirizine Solution, 2.5 mg/5ml, a generic [Read More]

Asthma Therapy Inhaled Drug Develpoment Assumed by Rigel

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer Inc. is returning full rights to the R343 program as a [Read More]

Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl

Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl

Perrigo today announced that its partner, Teva Pharmaceutical Industries, Ltd. (Nasdaq: TEVA), has received final OTC approval to sell and distribute fexofenadine HCl 60 mg and 180 mg tablets; the generic equivalents of Sanofi-Aventis’ Allegra 60 mg and 180 mg [Read More]

Latest Topics

remote host "www.fda.gov" not allowed
Warning: mime_content_type(/http://...@system/documents/system/img_fdagov_exitdisclaimer.png): failed to open stream: No such file or directory in /home4/netguy/public_html/allergychat.org/wp-content/themes/allergychat/cropper.php on line 401

Warning: finfo_file(/http://...@system/documents/system/img_fdagov_exitdisclaimer.png): failed to open stream: No such file or directory in /home4/netguy/public_html/allergychat.org/wp-content/themes/allergychat/cropper.php on line 409

MAJOR RECALL : Grain Craft Flour & Hostess Brands, LLC Issues Recall Possible Undeclared Peanut Residue In Certain Snack Products

Fast Facts FDA advises consumers with severe peanut allergies to avoid the following products being recalled because of [Read More]

RECALL : Udi’s Gluten Free Au Naturel Granola with UPC 6-98997-80615-8 and Best By 041913 12265 1

We have recently learned that Udi’s Healthy Foods LLC, in cooperation with the U.S. Food and Drug Administration [Read More]

Dominos Has A Gluten Free Pizza But Not A Gluten Free Kitchen

Dominos Has A Gluten Free Pizza But Not A Gluten Free Kitchen

Domino’s Pizza seems to have taken one step forward and two steps back move in the eyes of many familiar with [Read More]

Odwalla Chocolate Protein Monster recalled; Peanut Allergy – Severe Reactions

Odwalla Chocolate Protein Monster recalled; Peanut Allergy – Severe Reactions

  FOR IMMEDIATE RELEASE April 5, 2012 Contact: Susan Stribling Odwalla Inc. 404.676.4120 ODWALLA, INC. ISSUES [Read More]

Qualitest Pharmaceuticals Issues Voluntary, Nationwide Retail Level Recall of Four Lots of Butalbital, Acetaminophen, and Caffeine Tablets

Qualitest Pharmaceuticals today issued a voluntary nationwide  retail level recall of Butalbital, Acetaminophen, and [Read More]

Categories

Categories

Events Calendar

March  2017
Mon Tue Wed Thu Fri Sat Sun
   
  1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31